Clinical Trials Search at Vanderbilt-Ingram Cancer Center

ALL-IN - Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab

DEFINE-HT - DevelopmEnt of non-invasive cell-Free DNA to supplant INvasivE biopsy in Heart Transplantation

CORDIO HearO - AN INTERNATIONAL, MULTICENTER, OBSERVATIONAL, SINGLE-ARM, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEAROTM SYSTEM

LUX-Dx Heart Failure Sensors in an Insertable Cardiac Monitor System Clinical Study

OCEANIC-AF - A multicenter, international, randomized, active comparator-controlled, double-blind, double-dummy, parallel-group, 2-arm, Phase 3 study to compare the efficacy and safety of the oral FXIa inhibitor asundexian (BAY 2433334) with apixaban for the prevention of stroke or systemic embolism in male and female participants aged 18 years and older with atrial fibrillation at risk for stroke

Blood-based, Point-of-need Assessment of CAR-T Vector Load in DLBCL Patients Undergoing Axicabtagene Ciloleucel (axi-cel) Therapy: A Multi-Site Study

Lymphoma

GS-US-356-5413 Study of Females Exposed to Eleclazine

TRISOL: EARLY FEASIBILITY STUDY OF THE TRISOL SYSTEM PROTOCOL

RESPONDER-HF - Re-Evaluation of the Corvia Atrial Shunt Device in a Precision Medicine Trial to Determine Efficacy in Mildly Reduced or Preserved EF Heart Failure

ION-682884-CS12 - An Open-Label Extension Study to Assess the Long-Term Safety of
Eplontersen (ION-682884) in Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)